Lipoprotein(a) and coronary heart disease.

[1]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  P. Wilson,et al.  Effects of Age, Sex, and Menopausal Status on Plasma Lipoprotein(a) Levels The Framingham Offspring Study , 1993, Circulation.

[3]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[4]  Richard H. Myers,et al.  Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease , 1992, Circulation.

[5]  K. Anderson,et al.  Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. , 1992, Journal of the American College of Cardiology.

[6]  P. Wilson,et al.  The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). , 1991, Atherosclerosis.

[7]  R. Ferrell,et al.  Expressed hypervariable polymorphism of apolipoprotein (a). , 1991, American journal of human genetics.

[8]  E. Boerwinkle,et al.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. , 1991, The Journal of clinical investigation.

[9]  P. Wilson,et al.  Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease. , 1991, The American journal of cardiology.

[10]  R. Sato,et al.  Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment. , 1990, The Journal of biological chemistry.

[11]  E. Boerwinkle,et al.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.

[12]  W. Patsch,et al.  Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. , 1990, Journal of lipid research.

[13]  K. Berg,et al.  Inherited quantitative DNA variation in the LPA (“apolipoprotein (a)”) gene , 1990, Clinical genetics.

[14]  M. Koschinsky,et al.  Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. , 1990, Biochemistry.

[15]  J. Breslow,et al.  Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. , 1989, The Journal of clinical investigation.

[16]  A. Hamsten,et al.  Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid , 1989, Journal of internal medicine.

[17]  J. Scott,et al.  The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. , 1989, Journal of lipid research.

[18]  E. Boerwinkle,et al.  Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[20]  P. Wilson,et al.  Screening for lipoprotein[a] elevations in plasma and assessment of size heterogeneity using gradient gel electrophoresis. , 1989, Journal of lipid research.

[21]  G. Manis,et al.  Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons. , 1989, The Journal of biological chemistry.

[22]  N. Hilschmann,et al.  Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. , 1987, Biological chemistry Hoppe-Seyler.

[23]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[24]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[25]  J. Stamler,et al.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.

[26]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[27]  W. C. Breckenridge,et al.  Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[28]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[29]  A. Scanu,et al.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.

[30]  V. Armstrong,et al.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.

[31]  A. Scanu,et al.  Isolation of apolipoprotein(a) from lipoprotein(a). , 1985, Journal of lipid research.

[32]  A. Gotto,et al.  Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B , 1985, Arteriosclerosis.

[33]  G. Utermann,et al.  Protein composition of Lp(a) lipoprotein from human plasma , 1983, FEBS letters.

[34]  G. J. Jones,et al.  The inheritance of sinking‐pre‐beta lipo‐protein and its relation to the Lp(a) antigen * , 1982, Clinical genetics.

[35]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Hazzard,et al.  Radioimmunoassay of human plasma Lp(a) lipoprotein. , 1977, Journal of lipid research.

[37]  G. Dahlén,et al.  Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease , 1975, Clinical genetics.

[38]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[39]  K. Walton,et al.  A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis. , 1974, Atherosclerosis.

[40]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[41]  A. Allison,et al.  A human lipoprotein polymorphism. , 1962, The Journal of clinical investigation.

[42]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[43]  C. Furberg,et al.  Studies on an extra pre-beta lipoprotein fraction. , 1972, Acta medica Scandinavica. Supplementum.

[44]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .